Anti-GD2-800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-GD2-800CW, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma [Phase 1, Phase 2]